Stock Markets June 10, 2026 04:32 AM

EnQuest Shares Jump as Firm Agrees Major Malaysian Asset Purchase

Acquisition of stakes in four Malaysian offshore contracts would more than double output and sharply expand reserves, prompting strong market response

By Marcus Reed
Share
Twitter Reddit Facebook LinkedIn

EnQuest Plc stock climbed sharply after announcing an agreement to acquire stakes in four offshore Malaysian production sharing contracts for a maximum consideration of $833 million. The transaction, structured through three farm-out deals with Petronas units, would substantially increase production, reserves and resources while cutting operating costs, but requires shareholder approval and regulatory clearances because it meets the threshold for a reverse takeover under UK Listing Rules.

EnQuest Shares Jump as Firm Agrees Major Malaysian Asset Purchase
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • EnQuest agreed to acquire stakes in four Malaysian offshore production sharing contracts for up to $833 million via three farm-out deals with Petronas units.
  • The transaction is expected to boost production by 134% to over 100 thousand boe/d, raise 2P reserves by 85% to about 300 MMboe, and grow 2C resources by 46% to around 660 MMboe while lowering operating costs to $16/boe.
  • Because the deal crosses the size threshold relative to EnQuest's existing operations, it is classified as a reverse takeover under UK Listing Rules and requires a combined circular and prospectus and shareholder approval.

EnQuest Plc saw its shares surge on the day of a major strategic announcement, with the stock up 21.7% to 23.25p and an intraday 52-week high of 23.7p. The jump followed the company disclosing a definitive agreement to acquire stakes in four offshore production sharing contracts in Malaysia for a maximum aggregate consideration of $833 million.

The transaction is being executed through three separate farm-out agreements with units of Malaysia's national oil company Petronas - Carigali and E&P Malaysia. Under the terms disclosed, $554 million of the purchase price is payable up front on completion. The company has set a target completion date of 31 December 2026, subject to the receipt of regulatory approvals and the satisfaction of pre-emption rights conditions.


The market's pronounced reaction reflects the scale and metrics attached to the deal. Management projects the acquisition will raise EnQuest's production by 134% to exceed 100 thousand barrels of oil equivalent per day. At the same time, it would boost proved plus probable - 2P - reserves by 85% to roughly 300 million barrels of oil equivalent, and increase 2C contingent resources by 46% to around 660 million barrels of oil equivalent.

Alongside the volume and resource increases, the transaction is expected to materially lower unit operating costs to $16 per barrel of oil equivalent, a figure highlighted by the company as a key driver of the deal's value proposition.


Because the size of the acquisition exceeds a specific threshold relative to EnQuest's existing business, it is treated as a reverse takeover under UK Listing Rules. That classification triggers additional procedural requirements, including the need to produce a combined circular and prospectus and to obtain shareholder approval prior to completion.

The announcement also underscores an expanding strategic relationship between EnQuest and Petronas. The companies noted an ongoing partnership that has seen EnQuest recognized by Petronas as Operator of the Year in consecutive years. The Malaysian transaction extends EnQuest's Southeast Asian footprint following previous moves such as the acquisition of Harbour Energy's Vietnam business and new entries into Brunei and Indonesia.

Analysts had already priced meaningful upside into EnQuest's shares prior to the deal. The consensus analyst price target stood at about 29.72p before today's announcement, indicating the market had anticipated growth potential. The scale and clarity of the Malaysian transaction now provide a concrete catalyst that could help close the gap between the market price and consensus targets.

The broader UK market provided little support for the rally, with the FTSE 100 reported to have declined around 1.4% in the prior session, weighed down by energy majors, banks and healthcare names. Despite that wider backdrop, the combination of a transformational asset purchase, a confirmed Petronas partnership and a stated route to lower operating costs gave investors a strong reason to revalue EnQuest's equity substantially higher on the announcement.

Because this is a large-scale, transformational acquisition for EnQuest - shifting the company from a mid-sized North Sea operator toward a business with production above 100 kboepd - the deal carries multiple procedural and timing conditions before it becomes effective. Those conditions include regulatory approvals, pre-emption rights, and the additional shareholder votes and documentation required under the UK Listing Rules for reverse takeovers.

Investors and market participants will now be watching the regulatory and shareholder timetable closely as the company works toward the targeted completion date of 31 December 2026.

Risks

  • Completion is subject to regulatory approvals and pre-emption rights conditions that could delay or prevent the transaction - impacting the energy sector and equity markets.
  • The reverse takeover designation requires additional shareholder votes and a combined circular and prospectus, introducing execution and timing risk for the company and its investors.
  • Broader market weakness, such as recent declines in the FTSE 100 driven by energy majors, banks and healthcare stocks, could weigh on stock performance despite the deal-specific positive developments.

More from Stock Markets

Tekfen Holding Shares Slide After Major Shareholder Enters Sale Talks Jun 10, 2026 HBM Holdings Shares Rise After China Accepts IND for HBM7004 Jun 10, 2026 Nike Shares Slip After RBC Downgrade, Analysts Cite Slower Recovery and Limited Near-Term Catalysts Jun 10, 2026 Sanofi Shares Retreat After Halt of Phase 3 MOBILIZE Trial for Riliprubart Jun 10, 2026 Fielmann Shares Rally After Deutsche Bank Starts Coverage with Buy Rating Jun 10, 2026